Review of services provided by pharmacies that promote healthy living

International Journal of Clinical Pharmacy

Volumn 34, Issue 3, 2012, Pages 399-409

  Brown, David ^a   Portlock, Jane ^b   Rutter, Paul ^c  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Community pharmacy; Health care delivery; Literature review; Public health; United Kingdom

Indexed keywords

ANTICOAGULATION; ASTHMA; AUSTRALIA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DRUG USE; EMERGENCY CONTRACEPTION; EUROPE; EVIDENCE BASED PRACTICE; HEALTH PROMOTION; HEALTH SERVICES RESEARCH; HEALTHY LIVING PHARMACY; HEART FAILURE; HORMONAL CONTRACEPTION; HUMAN; HYPERTENSION; IMMUNIZATION; INTERVENTION STUDY; MEDICAL RESEARCH; NEW ZEALAND; OSTEOPOROSIS; PHARMACY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLICATION; QUALITY CONTROL; REVIEW; SEXUAL HEALTH; SMOKING CESSATION; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; WEIGHT CONTROL;

COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS; HEALTH SERVICES RESEARCH; HEALTH STATUS; HUMANS; HYPERTENSION; RISK REDUCTION BEHAVIOR; SMOKING CESSATION;

EID: 84862982451     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9634-2     Document Type: Review

References (100)

1. Department of Health. Tackling health inequalities: a programme for action. London: Department of Health 2003. Available at http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4008268. Accessed 8 Dec 2011.
2. Department of Health. Vision for pharmacy in the new NHS. Department of Health, London 2003. Available at http://www.dh. gov.uk/en/ Publicationsandstatistics/Publications/Publications PolicyAndGuidance/DH- 4070097. Accessed 8 Dec 2011.
3. Department of Health. Choosing health through pharmacy-a programme for pharmaceutical public health 2005-2015, 2005. Available at http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH-4107494. Accessed 8 Dec 2011.
4. Department of Health. Supporting people with long term conditions to self care: a guide to developing local strategies and good practice 2006. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAnd Guidance/DH-4130725. Accessed 8 Dec 2011.
5. Department of Health. Pharmacy in England: building on strengths, delivering the future 2008. Available at http://www.official-documents.gov.uk/ document/cm73/7341/7341.asp. Accessed 8 Dec 2011.
6. Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public's health. Report 1: evidence from the peer-reviewed literature 1990-2001, 2003. Available at http://eprints. nottingham.ac.uk/1571/. Accessed 30 Jan 2012.
7. Blenkinsopp A, Anderson C, Armstrong M. The contribution of community pharmacy to improving the public's health. Report 2: evidence from the UK non peer-reviewed literature 1990-2002, 2003. Available at http://eprints. nottingham.ac.uk/1572/. Accessed 30 Jan 2012.
8. Armstrong M, Lewis R, Anderson C, Blenkinsopp A. The contribution of community pharmacy to improving the public's health. Report 3, an overview of evidence base from 1990-2002, 2005. http://eprints.nottingham.ac.uk/1573/. Accessed 30 Jan 2012.
9. Anderson C, Blenkinsopp A, Bissell P, Armstrong,M. The contribution of community pharmacy to improving the public's health. Report 4: local examples of service provision 2005. Available at http://eprints.nottingham.ac.uk/1574/. Accessed 30 Jan 2012.
10. Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public's health: literature review update 2004-2007, 2008. Available at http://eprints. nottingham.ac.uk/1575/. Accessed 30 Jan 2012.
11. Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public's health: summary report of the literature review 1990-2007, 2009. Available at http://eprints.nottingham.ac.uk/1576/. Accessed 30 Jan 2012.
12. Department of Health. National Service Framework for older people in London 2001. Available at http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/@dh/@en/documents/digital asset/dh-4071283.pdf. Accessed 8 Dec 2011.
13. Maguire TA, McElnay JC, Drummond A. A randomised controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325-31.
14. Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches linking hospital to the community. J Pharm Pract Res. 2002;32(1):57-62.
15. Dent LA, Harris KJ, Noonan CW. Randomised trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194-210.
16. Crealey G, McElnay JC, Maguire TA. Costs and effects associated with a community pharmacy based smoking cessation programme. Pharmacoeconomics. 1998;12:323-33.
17. Sinclair H, Silcock J, Bond CM, Lennox S, Winfield AJ. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract. 1999;7:107-12.
18. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage of change model of smoking cessation: a randomised controlled trial in Scotland. Tobacco Control. 1998;7:253-61.
19. Sinclair HK,Bond CM, Stead LF. Communitypharmacypersonnel interventions for smoking cessation. Cochrane database of systematic reviews 2008, Issue 1. http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003698/frame. html. Accessed 8 Dec 2011. doi:10.1002/14651858.CD003698.pub2.
20. Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195-207.
21. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Pub Health Med. 2003;25(2):144-53.
22. Nola KM, Gourley DR, Portner TS, Gourley K, Solomon DK, Elam M, Regel B. (2000) Clinical and humanistic outcomes of a lipid management programme in the community pharmacy setting. J Am Pharm Assoc. 2000;40:166-73.
23. Simpson SA, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001;21(5):627-35.
24. Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS. A randomised trial of the effect of community pharmacy intervention on cholesterol risk: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149-55.
25. Glynn LG, Murphy AW, Smith M, Schroeder K, Fahey T. Interventions to improve blood pressure in patients with hypertension. Cochrane database of systematic reviews, CD005182 2008. Available at http://mrw.interscience.wiley. com/cochrane/clsysrev/articles/CD005182/frame.html. Accessed 8 Dec 2011.
26. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770-81.
27. Carter BL, Rogers M, Daly J, Zheng S, James P. The potency of team-based care interventions in hypertension. Arch Int Med. 2009;169(19):1748-55.
28. Carter BL, Ardery G, Dawson J, James PA, Bergus G, Doucette WR, Chrischilles EA, Franciscus CL. Physician and pharmacists collaboration in improved blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
29. Jones C, Simpson SH, Mitchell D, Haggerty S, Campbell N, Then K. Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Can J Cardiol. 2008;24(7):561-7.
30. Botomino A, Bruppacher R, Krahenbuehl S, Hersberger KE. Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies. Pharm World Sci. 2007;30:222-6.
31. Blenkinsopp A, Anderson C, Armstrong M. Community pharmacy's contribution to improving the public's health: the case of weight management. Int J Pharm Pract. 2008;16:123-5.
32. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Phar-macother. 2007;41:1569-82.
33. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36.
34. Fornos JA, Andres NF, Andres JC, Guerra MM, Egea B. A pharmacotherapy follow-up programme in patients with Type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28(2):65-72.
35. Anaya JP, Rivera JO, Lawson K, Garcia J, Luna J, Oritz M. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65(19):1841-5.
36. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, LauP,PetersonG,Stewart K,TaylorS,WilkinsonJ.The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24:677-83.
37. McLean DL, McAllister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus. Arch Int Med. 2008;168(21):2355-61.
38. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of hypertension medication therapy management programmes in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164-70.
39. Newbould J, Taylor D. Living with plenty: meeting the challenges of diabetes-the twenty first century role of pharmacy and pharmaceutical innovation in the treatment and prevention of diabetes mellitus. School of Pharmacy, University of London 2008. Available at http://www.pharmacy.ac.uk/fileadmin/docu ments/News/Living-with-Plenty.pdf. Accessed 8 Dec 2011.
40. Benavides S, Rodriguez JC, Manuscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2009;43(1):85-97.
41. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Brusselle G. Effectiveness of pharmacist intervention for asthma control improvement. Eur Resp J. 2008;31(4):790-9.
42. Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P. Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharm World Sci. 2008;30(6):869-75.
43. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133-47.
44. Kritikos V, Armour CL, Bosnic-Anticevich SZ. Interactive small-group asthma education in the community pharmacy setting: a pilot study. J Asthma. 2007;44(1):57-64.
45. Saini B, Filipovska F, Bosnic-Anticevich S, Taylo S, Krass I, Armour C. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health. 2008;16(2):100-8.
46. Basheti IA, Armour CL, Bosnich-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72(1):26-33.
47. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure. Arch Intern Med. 2008;168(7):687-94.
48. Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soranio JB. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Resp Med. 2009; 103:839-45.
49. Efthymiou N, Crampton R. Establishing an anticoagulation service in community pharmacy. Pharmacy Management. 2007; 23(4):10-5.
50. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2006;46(2):168-82.
51. Marrero W, Hernandez L, Garcia R, Gutierrez LM. A programme of immunisation against influenza in adults aged 65 years or older in one community pharmacy in Puerto Rica. Puerto Rico Health Sci J. 2006;25(1):35-42.
52. Fuchs J. The provision of pharmaceutical advice improves patient vaccination status. Pharm Pract. 2006;4(4):163-7.
53. Noble K, Holden M, Warner GA. solution to improving uptake of hepatitis B immunisation in at risk groups, through collaboration and adopting an integrated approach with pharmacists as service providers. Int J Pharm Pract. 2010;18(2):43.
54. Landau SC, Tapias MP, McGhee BT. Birth control within each: a national survey of women's attitudes to, and interest in pharmacy access to hormonal contraception. Contraception. 2006;74(6): 463-70.
55. McAllister KF, Elliott L, Thomson DA, Bigrigg A, Mackie CM. Evaluation of a young person's sexual health service in a commercial setting. J Fam Plann Reprod Health Care. 2002;28(4):203-6.
56. Mackie CM, Elliott L, Bigrigg A, McAllister KF. Public and private collaboration in establishing a young person's sexual health clinic in a commercial setting. J Fam Plann Reprod Health Care. 2002;28(4):201-3.
57. Van Bergen J, Postma M, Peerbooms P, Spangenberg A, Tjen-ATak J, Bindels P. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatisin a high-risk health centre population in Amsterdam using mailed home-collected urine samples. Int J STD AIDS. 2004;15:791-802.
58. Baraitser P, Pearce V, Holmes J, Horne N, Boynton PM. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual Saf Health Care. 2007;16:303-7.
59. Dabrera G, Pinson D, Whiteman S. Chlamydia screening by community pharmacists: a qualitative study. J Fam Plan Reprod Health Care. 2011;37(1):17-21.
60. Brabin L, Thomas G, Hopkins M, O'Brien K, Roberts SA. Delivery of Chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Women's Health. 2009;9:7.
61. National Audit Office. Department of health-young people's sexual health: the National Chlamydia screening programme 2009. Available at http://www.nao.org.uk/publications/0809/young-peoples-sexual-health.aspx. Accessed 8 Dec 2011.
62. Anderson C, Blenkinsopp A. Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence. Hum Reprod. 2006;21(1):272-84.
63. Raine TR, Harper CC, Rocca CH, Fischer R, Padian N, Klausner JD, Darney PD. Direct access to emergency contraception through pharmacies and effect on unintended pregnancies and STIs: a randomised controlled trial. JAMA. 2005;293:54-62.
64. Marston C, Meltzer M, Majeed A. Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. BMJ. 2005;331:271.
65. Britton R, Scott J. Community pharmacy services to drug mis-users in the south west of England: results of the 2003-2004 postal survey. Int J Pharm Pract. 2006;14:235-41.
66. Matheson C, Bond CM, Tinelli M. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. J Public Health. 2007;29(4):350-7.
67. LawrieT,MathesonC,BondCM,RobertsK.Pharmacycustomers' views and experiences of using pharmacies which provide drug misuse services. Drug Alcohol Rev. 2004;23(2):195-202.
68. Sheridan J, Manning V, Ridge G, Mayet S, Strang J. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005. Addiction. 2007;102(11):1824-30.
69. Jaffray M, Matheson C, Bond CM, Lee AJ, McLernon DJ, Johnstone A, Davidson B, Skea L. A cluster randomised trial of enhanced pharmacy services (EPS) to improve outcomes for patients on methadone maintenance therapy. Int J Pharm Pract. 2011;19(S1):4.
70. Cameron J, Gilchrist G, Roberts K. Needle exchange services: a profile of service users in community pharmacies and other settings. Int J Pharm Pract. 2004;12:211-5.
71. Watson MC, Inch M, Jaffray M, Stewart D. Screening and brief intervention for alcohol misuse delivered in a community pharmacy setting: a pilot study. Int J Pharm Pract. 2011;19(1):5.
72. Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review. Int J Pharm Pract. 2009;17(4):199-205.
73. McCaig D, Fitzgerald N, Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists' practice, knowledge, views and confidence. Int J Pharm Pract. 2010;19:171-8.
74. Horsfield E, Sheridan J, Anderson C. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. Int J Pharm Pract. 2010;19:192-200.
75. Sheridan J, Wheeler A, Chen L. Screening and brief interventions for alcohol: attitudes, knowledge and experience of community pharmacists in Auckland. N Z Drug Alcohol Rev. 2008;27(4):380-7.
76. Fitzgerald N, McCaig DJ, Watson H, Thomson D, Stewart DC. Development, implementation and evaluation of a pilot project to deliver interventions on alcohol issues in community pharmacies. Int J Pharm Pract. 2008;16(1):17-22.
77. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004;44(2):161-7.
78. Lata PF, Binkley NC, Elliott ME. Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause. 2002;9(6):449-55.
79. Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc. 2002;42(1):101-10.
80. MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacother-apy. 2005;25(3):379-86.
81. Summers KM, Brock TP. Impact of pharmacist-led community bone mineral density screenings. Ann Pharmacother. 2005;39: 243-8.
82. Naunton M, Peterson GM, Jones G. Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis. Ann Pharmacother. 2006;40(1):38-44.
83. Johnson JF, Koenigsfeld C, Hughell L, Parsa RA, Bravard S. Bone health screening, education and referral project in northwest Iowa: creating a model for community pharmacies. J Am Pharm Assoc. 2008;48(3):379-87.
84. Crockett JA, Taylor SJ, McLeod LJ. Patient responses to an integrated service, initiated by community pharmacists, for the prevention of osteoporosis. Int J Pharm Pract. 2008;16(2):65-72.
85. Youssef S. Patients taking warfarin: problems revealed by medicines use reviews. Pharm J. 2008;280:662.
86. Portlock J, Holden M, Patel S. A community pharmacy asthma MUR project in Hampshire and the Isle of Wight. Pharm J. 2009;282:109-12.
87. Webb M. Rapid review of the evidence on the effectiveness of community pharmacy minor ailment schemes. National Public Health Service for Wales, September 2007, 2007. Available at http://www2.nphs.wales.nhs.uk:8080/ pharmaceuticalphtdocs.nsf/($all)/53dc35520a7dddc08025736f00471a11/ $file/lit%20review% 20minor%20ailments%20v6.doc. Accessed 8 Dec 2011.
88. Anonymous. Pharmaceutical needs assessment (PNA). Heart of Birmingham Teaching Primary Care Trust, Birmingham 2010.
89. Blenkinsopp A, Noyce PR. Minor illness management in primary care: a reviewof community pharmacy NHS schemes. Department of Medicines Management, University of Keele 2002. Available at http://www.keele.ac.uk/depts/mm/ Publications/documents/Minor IllnessDec2002.pdf. Accessed 8 Dec 2011.
90. Blenkinsopp A, Holmes J, Mitra G, Pringle M. Joining up self-care: evaluation of a PCT-wide programme of support for self-care. Primary Health Care Res Devel. 2009;10:83-97.
91. Hind C, Bond C, Lee A, van Teijlingen E. Travel medicine services from community pharmacy: evaluation of a pilot service. Pharm J. 2008;281:625-8.
92. Maunder PEV, Landes DP. An evaluation of the role played by community pharmaciesin oral healthcare situated in a primary care trust in the north of England. Br Dent J. 2005;199(4):219-23.
93. Ewan D. Evaluation of mental health care interventions made by three community pharmacists. Int J Pharm Pract. 2001;9:225.
94. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack W, Gra-bowsy J. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2009;37(4):727-36.
95. Aryana M, Coggins N, Hudson S, McKellar S, Grant E, Bryson S, Edwards N. Evaluation of a pharmacy-led community based, health information network to promote cancer prevention. Pharm World Sci. 2009;31(1):46-7.
96. McGuire TR, Leypoldt M, Narducci WA, Ward K. Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme. J Eval Clin Pract. 2007;13(1):146-9.
97. Anonymous. Patients invited to walk to health by pharmacists in Norfolk initiative. Pharm J. 2008; 281-410.
98. Anderson C, Rajyaguru R. The role of community pharmacists and medicines counter assistants in health promotion: reflections from a folic acid campaign. Int J Pharm Pract. 2002;3:17-22.
99. Jong-Van De, den Berg LTW. Monitoring of the folic acid supplementation program in the Netherlands. Food Nutr Bull. 2008;29(2):S210-3.
100. Meijer WM, de Smit DJ, Jurgens RA, Van den Berg LTW de Jong. Improved preconceptional use of folic acid after patient education in pharmacies: promising results of a pilot study in the Netherlands. Int J Pharm Pract. 2005;13(1):47-52.